Somatostatin and its 2A receptor in dorsal root ganglia and dorsal horn of mouse and human

Expression, trafficking and possible role in pain

Tie Jun S Shi, Qiong Xiang, Ming Dong Zhang, Swapnali Barde, Ylva Kai-Larsen, Kaj Fried, Anna Josephson, Laura Glück, Sergey M. Deyev, Andrei V. Zvyagin, Stefan Schulz, Tomas Hökfelt

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Background: Somatostatin (SST) and some of its receptor subtypes have been implicated in pain signaling at the spinal level. In this study we have investigated the role of SST and its sst2A receptor (sst2A) in dorsal root ganglia (DRGs) and spinal cord.Results: SST and sst2A protein and sst2 transcript were found in both mouse and human DRGs, sst2A-immunoreactive (IR) cell bodies and processes in lamina II in mouse and human spinal dorsal horn, and sst2A-IR nerve terminals in mouse skin. The receptor protein was associated with the cell membrane. Following peripheral nerve injury sst2A-like immunoreactivity (LI) was decreased, and SST-LI increased in DRGs. sst2A-LI accumulated on the proximal and, more strongly, on the distal side of a sciatic nerve ligation. Fluorescence-labeled SST administered to a hind paw was internalized and retrogradely transported, indicating that a SST-sst2A complex may represent a retrograde signal. Internalization of sst2A was seen in DRG neurons after systemic treatment with the sst2 agonist octreotide (Oct), and in dorsal horn and DRG neurons after intrathecal administration. Some DRG neurons co-expressed sst2A and the neuropeptide Y Y1 receptor on the cell membrane, and systemic Oct caused co-internalization, hypothetically a sign of receptor heterodimerization. Oct treatment attenuated the reduction of pain threshold in a neuropathic pain model, in parallel suppressing the activation of p38 MAPK in the DRGs. Conclusions: The findings highlight a significant and complex role of the SST system in pain signaling. The fact that the sst2A system is found also in human DRGs and spinal cord, suggests that sst2A may represent a potential pharmacologic target for treatment of neuropathic pain.

Original languageEnglish
Article number12
JournalMolecular Pain
Volume10
Issue number1
DOIs
Publication statusPublished - 13 Feb 2014
Externally publishedYes

Fingerprint

Human Trafficking
Spinal Ganglia
Pain
Somatostatin
Octreotide
Neuralgia
Neurons
Spinal Cord
Substantia Gelatinosa
Cell Membrane
Peripheral Nerve Injuries
Pain Threshold
somatostatin receptor 2
Spinal Cord Dorsal Horn
p38 Mitogen-Activated Protein Kinases
Sciatic Nerve
Ligation
Proteins
Therapeutics
Fluorescence

Keywords

  • Axonal transport
  • Nerve injury
  • Neuropeptide
  • NPY receptor
  • Receptor internalization
  • Retrograde signaling

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Molecular Medicine
  • Cellular and Molecular Neuroscience

Cite this

Somatostatin and its 2A receptor in dorsal root ganglia and dorsal horn of mouse and human : Expression, trafficking and possible role in pain. / Shi, Tie Jun S; Xiang, Qiong; Zhang, Ming Dong; Barde, Swapnali; Kai-Larsen, Ylva; Fried, Kaj; Josephson, Anna; Glück, Laura; Deyev, Sergey M.; Zvyagin, Andrei V.; Schulz, Stefan; Hökfelt, Tomas.

In: Molecular Pain, Vol. 10, No. 1, 12, 13.02.2014.

Research output: Contribution to journalArticle

Shi, TJS, Xiang, Q, Zhang, MD, Barde, S, Kai-Larsen, Y, Fried, K, Josephson, A, Glück, L, Deyev, SM, Zvyagin, AV, Schulz, S & Hökfelt, T 2014, 'Somatostatin and its 2A receptor in dorsal root ganglia and dorsal horn of mouse and human: Expression, trafficking and possible role in pain', Molecular Pain, vol. 10, no. 1, 12. https://doi.org/10.1186/1744-8069-10-12
Shi, Tie Jun S ; Xiang, Qiong ; Zhang, Ming Dong ; Barde, Swapnali ; Kai-Larsen, Ylva ; Fried, Kaj ; Josephson, Anna ; Glück, Laura ; Deyev, Sergey M. ; Zvyagin, Andrei V. ; Schulz, Stefan ; Hökfelt, Tomas. / Somatostatin and its 2A receptor in dorsal root ganglia and dorsal horn of mouse and human : Expression, trafficking and possible role in pain. In: Molecular Pain. 2014 ; Vol. 10, No. 1.
@article{e7a25820f38a4084a5eac9071f9c57ca,
title = "Somatostatin and its 2A receptor in dorsal root ganglia and dorsal horn of mouse and human: Expression, trafficking and possible role in pain",
abstract = "Background: Somatostatin (SST) and some of its receptor subtypes have been implicated in pain signaling at the spinal level. In this study we have investigated the role of SST and its sst2A receptor (sst2A) in dorsal root ganglia (DRGs) and spinal cord.Results: SST and sst2A protein and sst2 transcript were found in both mouse and human DRGs, sst2A-immunoreactive (IR) cell bodies and processes in lamina II in mouse and human spinal dorsal horn, and sst2A-IR nerve terminals in mouse skin. The receptor protein was associated with the cell membrane. Following peripheral nerve injury sst2A-like immunoreactivity (LI) was decreased, and SST-LI increased in DRGs. sst2A-LI accumulated on the proximal and, more strongly, on the distal side of a sciatic nerve ligation. Fluorescence-labeled SST administered to a hind paw was internalized and retrogradely transported, indicating that a SST-sst2A complex may represent a retrograde signal. Internalization of sst2A was seen in DRG neurons after systemic treatment with the sst2 agonist octreotide (Oct), and in dorsal horn and DRG neurons after intrathecal administration. Some DRG neurons co-expressed sst2A and the neuropeptide Y Y1 receptor on the cell membrane, and systemic Oct caused co-internalization, hypothetically a sign of receptor heterodimerization. Oct treatment attenuated the reduction of pain threshold in a neuropathic pain model, in parallel suppressing the activation of p38 MAPK in the DRGs. Conclusions: The findings highlight a significant and complex role of the SST system in pain signaling. The fact that the sst2A system is found also in human DRGs and spinal cord, suggests that sst2A may represent a potential pharmacologic target for treatment of neuropathic pain.",
keywords = "Axonal transport, Nerve injury, Neuropeptide, NPY receptor, Receptor internalization, Retrograde signaling",
author = "Shi, {Tie Jun S} and Qiong Xiang and Zhang, {Ming Dong} and Swapnali Barde and Ylva Kai-Larsen and Kaj Fried and Anna Josephson and Laura Gl{\"u}ck and Deyev, {Sergey M.} and Zvyagin, {Andrei V.} and Stefan Schulz and Tomas H{\"o}kfelt",
year = "2014",
month = "2",
day = "13",
doi = "10.1186/1744-8069-10-12",
language = "English",
volume = "10",
journal = "Molecular Pain",
issn = "1744-8069",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Somatostatin and its 2A receptor in dorsal root ganglia and dorsal horn of mouse and human

T2 - Expression, trafficking and possible role in pain

AU - Shi, Tie Jun S

AU - Xiang, Qiong

AU - Zhang, Ming Dong

AU - Barde, Swapnali

AU - Kai-Larsen, Ylva

AU - Fried, Kaj

AU - Josephson, Anna

AU - Glück, Laura

AU - Deyev, Sergey M.

AU - Zvyagin, Andrei V.

AU - Schulz, Stefan

AU - Hökfelt, Tomas

PY - 2014/2/13

Y1 - 2014/2/13

N2 - Background: Somatostatin (SST) and some of its receptor subtypes have been implicated in pain signaling at the spinal level. In this study we have investigated the role of SST and its sst2A receptor (sst2A) in dorsal root ganglia (DRGs) and spinal cord.Results: SST and sst2A protein and sst2 transcript were found in both mouse and human DRGs, sst2A-immunoreactive (IR) cell bodies and processes in lamina II in mouse and human spinal dorsal horn, and sst2A-IR nerve terminals in mouse skin. The receptor protein was associated with the cell membrane. Following peripheral nerve injury sst2A-like immunoreactivity (LI) was decreased, and SST-LI increased in DRGs. sst2A-LI accumulated on the proximal and, more strongly, on the distal side of a sciatic nerve ligation. Fluorescence-labeled SST administered to a hind paw was internalized and retrogradely transported, indicating that a SST-sst2A complex may represent a retrograde signal. Internalization of sst2A was seen in DRG neurons after systemic treatment with the sst2 agonist octreotide (Oct), and in dorsal horn and DRG neurons after intrathecal administration. Some DRG neurons co-expressed sst2A and the neuropeptide Y Y1 receptor on the cell membrane, and systemic Oct caused co-internalization, hypothetically a sign of receptor heterodimerization. Oct treatment attenuated the reduction of pain threshold in a neuropathic pain model, in parallel suppressing the activation of p38 MAPK in the DRGs. Conclusions: The findings highlight a significant and complex role of the SST system in pain signaling. The fact that the sst2A system is found also in human DRGs and spinal cord, suggests that sst2A may represent a potential pharmacologic target for treatment of neuropathic pain.

AB - Background: Somatostatin (SST) and some of its receptor subtypes have been implicated in pain signaling at the spinal level. In this study we have investigated the role of SST and its sst2A receptor (sst2A) in dorsal root ganglia (DRGs) and spinal cord.Results: SST and sst2A protein and sst2 transcript were found in both mouse and human DRGs, sst2A-immunoreactive (IR) cell bodies and processes in lamina II in mouse and human spinal dorsal horn, and sst2A-IR nerve terminals in mouse skin. The receptor protein was associated with the cell membrane. Following peripheral nerve injury sst2A-like immunoreactivity (LI) was decreased, and SST-LI increased in DRGs. sst2A-LI accumulated on the proximal and, more strongly, on the distal side of a sciatic nerve ligation. Fluorescence-labeled SST administered to a hind paw was internalized and retrogradely transported, indicating that a SST-sst2A complex may represent a retrograde signal. Internalization of sst2A was seen in DRG neurons after systemic treatment with the sst2 agonist octreotide (Oct), and in dorsal horn and DRG neurons after intrathecal administration. Some DRG neurons co-expressed sst2A and the neuropeptide Y Y1 receptor on the cell membrane, and systemic Oct caused co-internalization, hypothetically a sign of receptor heterodimerization. Oct treatment attenuated the reduction of pain threshold in a neuropathic pain model, in parallel suppressing the activation of p38 MAPK in the DRGs. Conclusions: The findings highlight a significant and complex role of the SST system in pain signaling. The fact that the sst2A system is found also in human DRGs and spinal cord, suggests that sst2A may represent a potential pharmacologic target for treatment of neuropathic pain.

KW - Axonal transport

KW - Nerve injury

KW - Neuropeptide

KW - NPY receptor

KW - Receptor internalization

KW - Retrograde signaling

UR - http://www.scopus.com/inward/record.url?scp=84893637715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893637715&partnerID=8YFLogxK

U2 - 10.1186/1744-8069-10-12

DO - 10.1186/1744-8069-10-12

M3 - Article

VL - 10

JO - Molecular Pain

JF - Molecular Pain

SN - 1744-8069

IS - 1

M1 - 12

ER -